GlobalData
GlobalData

Business Fundamentals

Paul, Weiss, Rifkind, Wharton & Garrison and Kirkland & Ellis top M&A legal advisers by value, volume in North America in H1 2023, finds GlobalData

Paul, Weiss, Rifkind, Wharton & Garrison and Kirkland & Ellis were the top mergers and acquisitions (M&A) legal advisers in the North American region for H1 2023 by value and volume, respectively, according to the latest legal advisers league table by GlobalData, which ranks legal advisers by the value and volume of M&A deals on […]
Read more

Goldman Sachs and Houlihan Lokey top M&A financial advisers by value, volume in North America in H1 2023, finds GlobalData

Goldman Sachs and Houlihan Lokey were the top mergers and acquisitions (M&A) financial advisers in the North American region for H1 2023 by value and volume, respectively, according to the latest financial advisers league table by GlobalData, which ranks financial advisers by the value and volume of M&A deals on which they advised. Based on […]
Read more

Chile real GDP to contract in 2023, forecasts GlobalData

The economy of Chile is expected to face several challenges in 2023, including lower copper production, fluctuations in commodity prices, high inflationary pressures, strict monetary policies, and low business confidence. These factors are likely to have a dampening effect on investments and domestic demand, resulting in subdued economic activities. Additionally, the global economic slowdown is […]
Read more

Average premium earned by top 20 global public insurers up by 3.3% in 2022, reveals GlobalData

The top global public insurance companies sustained their momentum in 2022, benefiting from increased insurance awareness following the COVID-19 pandemic and an economic rebound in most global markets. The average premium earned* of the top 20 global insurers grew by 3.3% while experiencing a slight 2.3% decline in total revenue, reveals GlobalData, a leading data […]
Read more

15 of top 20 biopharmaceutical companies by revenue report 5.2% YoY growth in 2022, reveals GlobalData

The biopharmaceutical industry had an exceptional year in 2022 with notable success for those with COVID-19 vaccines. The majority (15) of the top 20 publicly traded global innovative biopharmaceutical companies reported a 5.2% growth in the aggregate revenue to $868.97 billion from 2021 to 2022, reveals GlobalData, a leading data and analytics company.   GlobalData […]
Read more

FDA approval of Leqembi attracts mixed opinions from Twitter influencers, reveals GlobalData

Leqembi, the Alzheimer’s drug from Eisai and Biogen, has recently received the Food and Drug Administration’s (FDA) approval. Subsequently, Twitter influencer conversations around Leqembi witnessed a significant spurt, reveals the Social Media Analytics Platform of GlobalData, a leading data and analytics company. Shreyasee Majumder, Social Media Analyst at GlobalData, comments: “Influencers in the pharmaceutical business […]
Read more

Banking and payments industry takes center stage in AI discussions during Q2 2023, reveals GlobalData

Artificial intelligence (AI) continues to influence the way we live and work, generating a lot of discussions across different industries. The banking and payments industry had the highest discussions about AI after technology during the second quarter (Q2) of 2023, reveals the Company Filings Analytics Database of GlobalData, a leading data and analytics company. Misa […]
Read more
1 54 55 56 57 58 133